Financial burden in recipients of allogeneic hematopoietic cell transplantation

Biology of Blood and Marrow Transplantation

Volumn 20, Issue 9, 2014, Pages 1375-1381

  Khera, Nandita ^a   Chang, Yu hui ^a   Hashmi, Shahrukh ^b   Slack, James ^a   Beebe, Timothy ^b   Roy, Vivek ^c   Noel, Pierre ^a   Fauble, Veena ^a   Sproat, Lisa ^a   Tilburt, Jon ^b   Leis, Jose F ^a   Mikhael, Joseph ^a  

^a MAYO CLINIC   (United States)

^b MAYO CLINIC   (United States)

^c MAYO CLINIC   (United States)

Author keywords

Allogeneic hematopoietic cell transplantation; Economics; Financial burden; Quality of life

Indexed keywords

ADULT; AGE; AGED; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; ECONOMIC ASPECT; EDUCATION; EMPLOYMENT; FEMALE; FINANCIAL MANAGEMENT; FUNCTIONAL STATUS; GRAFT RECIPIENT; HEALTH BEHAVIOR; HEALTH STATUS; HUMAN; INCOME; INSURANCE; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PATIENT COMPLIANCE; QUALITY OF LIFE; QUESTIONNAIRE; RETIREMENT; RETROSPECTIVE STUDY; ADOLESCENT; ALLOTRANSPLANTATION; ECONOMICS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; IMMUNOSUPPRESSIVE TREATMENT; MIDDLE AGED; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INSURANCE COVERAGE; MALE; MIDDLE AGED; QUALITY OF LIFE; QUESTIONNAIRES; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS; YOUNG ADULT;

EID: 84906101310     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2014.05.011     Document Type: Article

References (31)

1. Weaver K.E., Rowland J.H., Bellizzi K.M., Aziz N.M. Forgoing medical care because of cost: assessing disparities in healthcare access among cancer survivors living in the United States. Cancer 2010, 116:3493-3504.
2. Shankaran V., Jolly S., Blough D., Ramsey S.D. Risk factors for financial hardship in patients receiving adjuvant chemotherapy for colon cancer: a population-based exploratory analysis. JClin Oncol 2012, 30:1608-1614.
3. Zafar S.Y., Peppercorn J.M., Schrag D., et al. The financial toxicity of cancer treatment: a pilot study assessing out-of-pocket expenses and the insured cancer patient's experience. Oncologist 2013, 18:381-390.
4. Goodwin J.A., Coleman E.A., Sullivan E., et al. Personal financial effects of multiple myeloma and its treatment. Cancer Nurs 2013, 36:301-308.
5. Ramsey S., Blough D., Kirchhoff A., et al. Washington State cancer patients found to be at greater risk for bankruptcy than people without a cancer diagnosis. Health Aff (Millwood) 2013, 32:1143-1152.
6. Ward E., Halpern M., Schrag N., et al. Association of insurance with cancer care utilization and outcomes. CA Cancer J Clin 2008, 58:9-31.
7. Jagsi R., Pottow J.A.E., Griffith K.A., et al. Long-term financial burden of breast cancer: experiences of a diverse cohort of survivors identified through population-based registries. JClin Oncol 2014, 32:1269-1276.
8. Hsu J., Price M., Huang J., et al. Unintended consequences of caps on Medicare drug benefits. NEngl J Med 2006, 354:2349-2359.
9. Serper M.P.K., Patzer R., Ladner D., Wolf M. Medication tradeoffs, non-adherence, and clinical outcomes among liver transplant recipients. Hepatology 2013, 58(Suppl 1):210A.
10. Hamilton J.G., Wu L.M., Austin J.E., et al. Economic survivorship stress is associated with poor health-related quality of life among distressed survivors of hematopoietic stem cell transplantation. Psychooncology 2013, 22:911-921.
11. Stewart S.K. Asurvey of hematopoietic cell transplant survivors and spouses: what are the major issues of concern post-transplant?. Biol Blood Marrow Transplant 2007, 13:52-53.
12. Majhail N.S., Rizzo J.D., Hahn T., et al. Pilot study of patient and caregiver out-of-pocket costs of allogeneic hematopoietic cell transplantation. Bone Marrow Transplant 2013, 48:865-871.
13. Rizzo J.D., Vogelsang G.B., Krumm S., et al. Outpatient-based bone marrow transplantation for hematologic malignancies: cost saving or cost shifting?. JClin Oncol 1999, 17:2811-2818.
14. Frey P., Stinson T., Siston A., et al. Lack of caregivers limits use of outpatient hematopoietic stem cell transplant program. Bone Marrow Transplant 2002, 30:741-748.
15. US Census Bureau -ACS. Median Household income in the past 12 months (in 2012 inflation - adjusted dollars). Available at: Accessed April 18,2014. http://factfinder2.census.gov/faces/nav/jsf/pages/download_center.xhtml#none.
16. US Department of Health & Human Services. 2012 HHS Poverty Guidelines. Available at:. Accessed September 1,2012. http://aspe.hhs.gov/poverty/12poverty.shtml.
17. McAlpine D.D., Beebe T.J., Davern M., Call K.T. Agreement between self-reported and administrative race and ethnicity data among Medicaid enrollees in Minnesota. Health Serv Res 2007, 42:2373-2388.
18. Davern M.C.K., Ziegenfuss J., Davidson G., et al. Validating health insurance coverage survey estimates: A comparison of self-reported coverage and administrative data records. Public Opin Q 2008, 72:241-259.
19. Ware J., Kosinski M., Keller S.D. A12-Item short-form health survey: construction of scales and preliminary tests of reliability and validity. Med Care 1996, 34:220-233.
20. Head B.A., Faul A.C. Development and validation of a scale to measure socioeconomic well-being in persons with cancer. JSupport Oncol 2008, 6:183-192.
21. Pidala J., Craig B.M., Lee S.J., et al. Practice variation in physician referral for allogeneic hematopoietic cell transplantation. Bone Marrow Transplant 2013, 48:63-67.
22. Ubel P.A., Abernethy A.P., Zafar S.Y. Full disclosure-out-of-pocket costs as side effects. NEngl J Med 2013, 369:1484-1486.
23. Sun C.L., Francisco L., Baker K.S., et al. Adverse psychological outcomes in long-term survivors of hematopoietic cell transplantation: a report from the Bone Marrow Transplant Survivor Study (BMTSS). Blood 2011, 118:4723-4731.
24. McFarlane J., Riggins J., Smith T.J. SPIKE$: a six-step protocol for delivering bad news about the cost of medical care. JClin Oncol 2008, 26:4200-4204.
25. Khera N., Chow E.J., Leisenring W.M., et al. Factors associated with adherence to preventive care practices among hematopoietic cell transplantation survivors. Biol Blood Marrow Transplant 2011, 17:995-1003.
26. Darkow T., Henk H., Thomas S., et al. Treatment interruptions and non-adherence with imatinib and associated healthcare costs. Pharmacoeconomics 2007, 25:481-496.
27. Dobbels F., Damme-Lombaert R.V., Vanhaecke J., Geest S.D. Growing pains: non-adherence with the immunosuppressive regimen in adolescent transplant recipients. Pediatr Transplant 2005, 9:381-390.
28. Paez K.A., Zhao L., Hwang W. Rising out-of-pocket spending for chronic conditions: a ten-year trend. Health Aff (Millwood) 2009, 28:15-25.
29. Agency for Healthcare Research and Quality. Disparities in healthcare quality among racial and ethnic groups: selected findings from the 2011 National Healthcare Quality and Disparities Reports. Fact Sheet. AHRQ Publication No. 12-0006-1-EF. Available at: Accessed September 19,2013. http://www.ahrq.gov/research/findings/nhqrdr/nhqrdr11/minority.html.
30. Ganz P.A. Ateachable moment for oncologists: cancer survivors, 10 million strong and growing!. JClin Oncol 2005, 23:5458-5460.
31. Moriates C., Shah N.T., Arora V.M. First, do no (financial) harm. JAMA 2013, 310:577-578.